Literature DB >> 9660500

Gene transfer to the human trabecular meshwork by anterior segment perfusion.

T Borrás1, Y Matsumoto, D L Epstein, D H Johnson.   

Abstract

PURPOSE: To determine whether adenovirus vectors are capable of transferring a foreign active protein to the perfused anterior segment of the human eye.
METHODS: Primary cultures from the human trabecular meshwork tissue were exposed to replication-deficient adenovirus Av1LacZ4 carrying the reporter beta-galactosidase gene driven by the Rous Sarcoma Virus promoter. Anterior segments of six pairs of human eyes from normal donors were placed in organ culture and were perfused with culture medium at 2.5 microl/min constant flow. After 24 hours, one eye was injected once with 8 X 10(8) plaque-forming units (20 microl) of the viral vector, while the paired eye was injected with vehicle. Forty-eight hours (four pairs) and 7 days (two pairs) after injection, tissues were fixed, were assayed histochemically for transferred enzyme activity, and were analyzed morphologically.
RESULTS: In monolayers, gene transfer occurs very efficiently in all distinct types of human outflow pathway cells. All human anterior segments injected with the adenovirus vector showed active gene transfer in cells of the outflow pathway: trabecular, juxtacanalicular, and inner wall of Schlemm's canal. Expression of the reporter enzyme was still present at 7 days after treatment. No activity was observed in any of the paired, vehicle-injected controls. Cell morphology and tissue architecture appeared normal in treated and control tissues, although some trabecular cell loss was observed in the corneoscleral and uveal regions of the perfused treated eyes.
CONCLUSIONS: Adenoviral vectors were able to transfer active foreign genes into perfused, intact human trabecular meshwork.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660500

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Targeted gene transfer to Schlemm's canal by retroperfusion.

Authors:  W Daniel Stamer; D W-H Chan; C Ross Ethier
Journal:  Exp Eye Res       Date:  2007-01-14       Impact factor: 3.467

2.  Novel AAV serotypes for improved ocular gene transfer.

Authors:  Corinna Lebherz; Albert Maguire; Waixing Tang; Jean Bennett; James M Wilson
Journal:  J Gene Med       Date:  2008-04       Impact factor: 4.565

Review 3.  Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma.

Authors:  Ankur Jain; Robert J Wordinger; Thomas Yorio; Abbot F Clark
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-07       Impact factor: 2.671

Review 4.  The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs.

Authors:  Teresa Borrás
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2017 Jan-Feb

5.  Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter.

Authors:  Paloma B Liton; Xialin Liu; W Daniel Stamer; Pratap Challa; David L Epstein; Pedro Gonzalez
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

6.  Transcription profiling in Drosophila eyes that overexpress the human glaucoma-associated trabecular meshwork-inducible glucocorticoid response protein/myocilin (TIGR/MYOC).

Authors:  Teresa Borrás; Tatiana V Morozova; Stefanie L Heinsohn; Richard F Lyman; Trudy F C Mackay; Robert R H Anholt
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

Review 7.  Gene transfer to the outflow tract.

Authors:  Yalong Dang; Ralitsa Loewen; Hardik A Parikh; Pritha Roy; Nils A Loewen
Journal:  Exp Eye Res       Date:  2016-04-27       Impact factor: 3.467

Review 8.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

9.  Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy.

Authors:  T Borrás; L K Buie; M G Spiga
Journal:  Gene Ther       Date:  2016-02-08       Impact factor: 5.250

10.  Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics.

Authors:  Laura Rodriguez-Estevez; Priyadarsini Asokan; Teresa Borrás
Journal:  Gene Ther       Date:  2019-10-14       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.